Variant report
Variant | nsv609851 |
---|---|
Chromosome Location | chr8:4325284-4357525 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568881729 | chr8:4325603-4325604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187875841 | chr8:4325623-4325624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528931763 | chr8:4325642-4325643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145209927 | chr8:4325643-4325644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534544086 | chr8:4325646-4325647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552582789 | chr8:4325687-4325688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11988893 | chr8:4325688-4325689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11984460 | chr8:4325698-4325699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556686780 | chr8:4325706-4325707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192441395 | chr8:4325709-4325710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111349259 | chr8:4325717-4325718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145626169 | chr8:4325722-4325723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35482894 | chr8:4325743-4325744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572100166 | chr8:4325748-4325749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114409786 | chr8:4325750-4325751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568848703 | chr8:4325759-4325760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565037542 | chr8:4325763-4325764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577039069 | chr8:4325775-4325776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544091256 | chr8:4325781-4325782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73660877 | chr8:4325785-4325786 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs375293855 | chr8:4325793-4325794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184488063 | chr8:4325809-4325810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548301833 | chr8:4325812-4325813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145286849 | chr8:4325817-4325818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527289862 | chr8:4325822-4325823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116565573 | chr8:4325834-4325835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571077133 | chr8:4325836-4325837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538517042 | chr8:4325839-4325840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550138731 | chr8:4325844-4325845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528476684 | chr8:4325848-4325849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568314344 | chr8:4325849-4325850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567855988 | chr8:4325851-4325852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201730598 | chr8:4325852-4325853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535595354 | chr8:4325863-4325864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73660878 | chr8:4325876-4325877 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs572161149 | chr8:4325897-4325898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539470604 | chr8:4325916-4325917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62479671 | chr8:4325924-4325925 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs577096315 | chr8:4325931-4325932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544472509 | chr8:4325934-4325935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1154072 | chr8:4325958-4325959 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs574673294 | chr8:4325961-4325962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140934058 | chr8:4325990-4325991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542339253 | chr8:4325994-4325995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538983817 | chr8:4325996-4325997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78691641 | chr8:4326046-4326047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115962797 | chr8:4326065-4326066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143755670 | chr8:4326070-4326071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188647623 | chr8:4326072-4326073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34549505 | chr8:4326090-4326091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4325600-4325800 | Enhancers | Gastric | stomach |
2 | chr8:4325800-4329000 | Weak transcription | Gastric | stomach |
3 | chr8:4328200-4330800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:4329000-4329400 | ZNF genes & repeats | Gastric | stomach |
5 | chr8:4330800-4331200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr8:4334400-4335000 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr8:4335200-4335800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr8:4335400-4335800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr8:4338400-4339000 | Enhancers | Fetal Heart | heart |
10 | chr8:4347000-4347400 | Enhancers | Gastric | stomach |
11 | chr8:4352800-4354200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr8:4353400-4353800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr8:4353400-4355000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr8:4353400-4355200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:4353600-4353800 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr8:4353600-4354400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr8:4353600-4354400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr8:4353800-4354000 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:4353800-4354000 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
20 | chr8:4353800-4354200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr8:4353800-4354400 | Enhancers | H1 Cell Line | embryonic stem cell |
22 | chr8:4353800-4354600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
23 | chr8:4354000-4354200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
24 | chr8:4354000-4354400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
25 | chr8:4354000-4355000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
26 | chr8:4354200-4354400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
27 | chr8:4354200-4355400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
28 | chr8:4354400-4355000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
29 | chr8:4355400-4355800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |